Which of the following can alter the gene expression by methylation and acetylation but not change the gene sequence?

Explanation

## Correct Answer: D. Epigenetics Epigenetics refers to heritable changes in gene expression that occur **without altering the underlying DNA sequence**. The two primary mechanisms are DNA methylation and histone acetylation. DNA methylation involves addition of methyl groups (CH₃) to cytosine residues in CpG dinucleotides, typically silencing genes. Histone acetylation adds acetyl groups to lysine residues on histone proteins, loosening chromatin structure and promoting gene expression. These modifications act as reversible "switches" that regulate which genes are turned on or off in a cell. In Indian clinical context, epigenetic dysregulation is increasingly recognized in cancer pathogenesis—for example, hypermethylation of tumor suppressor genes like VHL in renal cell carcinoma or BRCA1 in breast cancer. Epigenetic changes are also implicated in developmental disorders and metabolic diseases. Critically, these modifications do not change the DNA sequence itself; they only alter accessibility and expression of existing genes. This distinguishes epigenetics from true genetic mutations, which permanently alter the nucleotide sequence. ## Why the other options are wrong **A. Mutation** — A mutation is a permanent change in the DNA sequence itself—substitution, insertion, or deletion of nucleotides. Unlike epigenetic modifications, mutations directly alter the genetic code and cannot be reversed by methylation or acetylation. Mutations change the gene sequence; epigenetics does not. This is the fundamental discriminator. **B. Inversion** — Inversion is a chromosomal rearrangement in which a segment of DNA is reversed end-to-end, permanently altering the gene sequence order. Although the total DNA content may remain the same, the sequence is structurally changed. This is a chromosomal aberration, not an epigenetic modification. **C. Translocation** — Translocation is transfer of a chromosomal segment to a non-homologous chromosome, permanently altering gene sequence position and context. Like inversion, it changes the physical arrangement and sequence of genes. It is a chromosomal abnormality, not a reversible epigenetic mechanism. ## High-Yield Facts - **DNA methylation** silences genes by adding methyl groups to cytosine in CpG dinucleotides; **histone acetylation** activates genes by loosening chromatin structure. - Epigenetic changes are **reversible and heritable** but do **not alter the DNA sequence**—the core distinction from mutations. - **Hypermethylation of tumor suppressors** (VHL, BRCA1, p16) is a major mechanism of cancer development in Indian populations. - Epigenetic modifications regulate gene expression through **chromatin remodeling**, not nucleotide substitution. - **DNMT inhibitors** (azacitidine) and **HDAC inhibitors** are emerging cancer therapies targeting epigenetic dysregulation. ## Mnemonics **EPIMARK** **E**xpression altered, **P**rotein unchanged, **I**nheritable, **M**ethylation/**A**cetylation, **R**eversible, **K**eeps sequence intact. Use when distinguishing epigenetics from mutations. **Not-a-Mutation Rule** If the question says 'no change in sequence' and offers mutation/inversion/translocation vs. epigenetics, epigenetics is always correct—the others all change sequence. ## NBE Trap NBE pairs methylation/acetylation with chromosomal rearrangements (inversion, translocation) to trap students who confuse epigenetic mechanisms with structural chromosomal changes. The key discriminator is "without changing the gene sequence"—only epigenetics satisfies this. ## Clinical Pearl In Indian cancer registries, epigenetic silencing of tumor suppressors is now recognized as equally important as point mutations in driving malignancy. A patient with breast cancer may have normal BRCA1 sequence but hypermethylated BRCA1 promoter—same clinical outcome, different mechanism. This distinction guides targeted therapy selection (DNMT inhibitors vs. chemotherapy). _Reference: Robbins Ch. 7 (Genetic and Pediatric Diseases); Harper Biochemistry Ch. 36 (Gene Expression)_